Loxitane is a popular tricyclic antipsychotic drug for treating schizophrenia and demntia. The medication belongs to the class of dibenzoxazepines and relates to clozapine structurally. It offers an acute treatment of agitation conserning paranoid schizophrenia and bipolar disorders. The drug has no relation to benzodiazepines, so the misuse is rare. Probable side-effects are comparable to other antipsychotics.
At the market, Loxitane is also sold as PMS-Loxapine, Loxapine, Loxitane C.
Loxitane® is a trademark belonging to Watson Pharmaceuticals.